US Stock MarketDetailed Quotes

NAMSW NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM)

Watchlist
  • 9.730
  • +0.100+1.04%
Close Apr 26 16:00 ET
0Market Cap0.00P/E (TTM)

NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) Earnings Date

Currency: USD

Period

FY2023 Annual Report

--

Revenue(YoY)

14.09M

-86.28%
Net Income(YoY)

-176.94M

-681.73%
Analyst Rating

No Data

NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) Earnings Estimates

Revenue

EPS

EBIT

No Data

NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) Earnings Reports

  • NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 10-K: Annual report

    Feb 28 08:02 ET

  • NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 7, 2023 07:24 ET

  • NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 9, 2023 21:39 ET

  • NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 20-F: Registration statement / Annual report / Transition report

    Mar 31, 2023 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg